Ultrasound Guided Quadratus Lumborum Block for Postoperative Pain in Abdominoplasty
Pain
About this trial
This is an interventional treatment trial for Pain focused on measuring QLB, Abdominoplasty, Quadratus lumborum block
Eligibility Criteria
Inclusion Criteria:
- Standard abdominoplasty procedure
- Written informed consent
- Age ≥ 18 years
- Female
Exclusion Criteria:
- Patient's refusal
- Allergies to any study medication
- Inability to comprehend or participate in scoring scales
- Deformations that could possibly affect the spread of the local anesthetic in the quadratus lumborum muscle plane
- Quadratus lumborum muscle plane not seen in ultrasound examination
- Coagulopathy or on anticoagulants
Sites / Locations
- Hotel Dieu De France
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
QLB group
Control group
Patients will receive at the beginning of the surgery 0.2 ml/kg of 0.2% ropivacaine bilaterally. Procedure: Quadratus Lumborum Block type II, local anesthetic injection on the posterior border of the quadratus lumborum muscle Drug: Ropivacaine, 0.2 ml/kg of 0.2% ropivacaine
Patients will receive at the beginning of the surgery 0.2 ml/kg of 0.9% normal saline bilaterally. Procedure: Quadratus Lumborum Block type II, local anesthetic injection on the posterior border of the quadratus lumborum muscle Drug: Normal saline, 0.2 ml/kg of 0.9 % normal saline